GIP：肥満と中枢神経系 GIP シグナル.
- Published in:
- Journal of Japan Society for the Study of Obesity, 2023, v. 29, n. 3, p. 82
- By:
- Publication type:
- Article
Works matching IS 1343229X AND DT 2023 AND VI 29 AND IP 3
Results: 7
1
2
GLP-1 受容体作動薬：肥満症の標準治療薬となるか.
- Published in:
- Journal of Japan Society for the Study of Obesity, 2023, v. 29, n. 3, p. 76
- By:
- Publication type:
- Article
3
最新消化管ホルモン学 ―肥満症薬物療法の近未来像と展望を語る.
- Published in:
- Journal of Japan Society for the Study of Obesity, 2023, v. 29, n. 3, p. 75
- By:
- Publication type:
- Article
4
勤務形態や食習慣と就労者のメタボリックシンドローム リスクの関連：横断研究.
- Published in:
- Journal of Japan Society for the Study of Obesity, 2023, v. 29, n. 3, p. 107
- By:
- Publication type:
- Article
5
グレリン：体組成異常治療の突破口となるか？ 刺激と阻害の生理学と薬理学.
- Published in:
- Journal of Japan Society for the Study of Obesity, 2023, v. 29, n. 3, p. 102
- By:
- Publication type:
- Article
6
グルカゴン：生理作用，薬理作用，病態生理的意義， そして糖尿病・肥満症に対する診断と治療への応用.
- Published in:
- Journal of Japan Society for the Study of Obesity, 2023, v. 29, n. 3, p. 94
- By:
- Publication type:
- Article
7
肥満症シンデミック.
- Published in:
- Journal of Japan Society for the Study of Obesity, 2023, v. 29, n. 3, p. 73
- By:
- Publication type:
- Article